Duloxetine Hydrochloride

CAS 136434-34-9 37 current records 11 historicalSmall Molecule

Who holds supplier records for Duloxetine Hydrochloride? 37 organisations hold a current record for Duloxetine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 27 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (22), China (5), Spain (2), Taiwan (1) and 4 other countries (4); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Duloxetine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/duloxetine-hydrochloride

Reading the evidence

  • 37 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    22 of the 34 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 21 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (37)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Duloxetine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Duloxetine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (27)

Certificates of Suitability on the EDQM register for Duloxetine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 40 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2026-287 - Rev 00
Duloxetine hydrochloride, Process-II
Oct 2026—
SHANKUS PHARMA PRIVATE LIMITED MehsanaIN
CEP 2025-008 - Rev 00
Duloxetine hydrochloride
Sept 2026—
SHODHANA LABORATORIES PRIVATE LIMITED Medchal MalkajgiriIN
CEP 2026-269 - Rev 00
Duloxetine hydrochloride, Alternate Manufacturing Process
Sept 2026—
ALKEM LABORATORIES LIMITED MumbaiIN
CEP 2024-139 - Rev 01
Duloxetine hydrochloride
Sept 2026—
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2012-247 - Rev 02
Duloxetine hydrochloride
Jul 2026—
MOEHS IBERICA S.L. RubiES
CEP 2026-122 - Rev 00
Duloxetine hydrochloride, M02 milled, M02 micronised
Jun 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2012-305 - Rev 04
Duloxetine hydrochloride
Jun 2026—
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2014-012 - Rev 02
Duloxetine hydrochloride
Mar 2026—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2024-316 - Rev 00
Duloxetine hydrochloride
Oct 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2012-203 - Rev 04
Duloxetine hydrochloride
Sept 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2024-273 - Rev 01
Duloxetine hydrochloride, Process-K
Jul 2025—
TAPI NL B.V. AmsterdamNL
CEP 2012-311 - Rev 04
Duloxetine hydrochloride
Jan 2025—
EGIS Pharmaceuticals PLC BudapestHU
CEP 2023-144 - Rev 00
Duloxetine hydrochloride
Dec 2024Inspected Nov 2025
Hungary
LAURUS LABS LIMITED HyderabadIN
CEP 2023-132 - Rev 00
Duloxetine hydrochloride, Micronised, Form-A
Dec 2024—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2012-368 - Rev 01
Duloxetine hydrochloride
Jul 2024—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R1-CEP 2012-118 - Rev 03
Duloxetine hydrochloride
Jul 2023—
R L FINE CHEM PVT. LTD. GowribidanurIN
R0-CEP 2020-313 - Rev 00
Duloxetine hydrochloride
Oct 2022—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2012-220 - Rev 02
Duloxetine hydrochloride
Oct 2022—
Union Quimico Farmaceutica, S.A. (Uquifa S.A.) BarcelonaES
R0-CEP 2021-003 - Rev 00
Duloxetine hydrochloride, Process B
Oct 2022—
SCI PHARMTECH, INC. Taoyuan CityTW
R1-CEP 2012-217 - Rev 01
Duloxetine hydrochloride
Sept 2022—
ZHEJIANG YONGTAI PHARMACEUTICAL CO., LTD. DuqiaoCN
R1-CEP 2016-142 - Rev 00
Duloxetine hydrochloride
Mar 2022—
LUPIN LIMITED MumbaiIN
R1-CEP 2015-144 - Rev 00
Duloxetine hydrochloride
Mar 2022—
KRKA, d.d., Novo mesto Novo mestoSI
R1-CEP 2015-246 - Rev 00
Duloxetine hydrochloride
Mar 2022—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
R1-CEP 2015-166 - Rev 00
Duloxetine hydrochloride
Oct 2021—
SANECA PHARMACEUTICALS A.S. HlohovecSK
R1-CEP 2014-297 - Rev 00
Duloxetine hydrochloride
Aug 2021—
ESTEVE QUIMICA S.A. BarcelonaES
R1-CEP 2013-016 - Rev 02
Duloxetine hydrochloride
Jul 2021—
ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao TownCN
R1-CEP 2014-239 - Rev 00
Duloxetine hydrochloride
Aug 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (11)

Organisations whose Type II DMFs for Duloxetine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 11 historical records
  • India · Inactive DMF 29540 · filed Jul 2015
  • JIANGSU HANSOH PHARMACEUTICAL CO LTD
    Inactive DMF 25625 · filed Dec 2011
  • India · Inactive DMF 19631, 24274 · filed Oct 2010
  • Italy · Inactive DMF 23133 · filed Sept 2009
  • India · Inactive DMF 22867 · filed Jun 2009
  • ZHEJIANG HISOAR PHARMACEUTICAL CO LTD CHUANNAN BRANCH
    Inactive DMF 22086 · filed Sept 2008
  • RANBAXY LABORATORIES LTD
    Inactive DMF 21838 · filed Jul 2008
  • CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD
    Inactive DMF 21801 · filed Jul 2008
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
    China · Inactive DMF 21385 · filed Feb 2008
  • Italy · Inactive DMF 19974 · filed Nov 2006
  • MATRIX LABORATORIES LTD
    Inactive DMF 19860 · filed Oct 2006

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Duloxetine hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the treatment of major depressive disorder and generalized anxiety disorder. It is also indicated for managing neuropathic pain associated with diabetic peripheral neuropathy and fibromyalgia.

Chemical identity

IUPAC name
(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride
Canonical SMILES
CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl
InChIKey
BFFSMCNJSOPUAY-LMOVPXPDSA-N
Synonyms
Cymbalta API, (s)-(+)-duloxetine hydrochloride, ariclaim, cymbalta, duloxetine boehringer ingelheim, duloxetine mylan, duloxetine (as hydrochloride), duloxetine hcl, ly-248686 hcl, ly248686 hcl, nsc-759112, xeristar

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of action
Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors

Therapeutic areas

DepressionAnxiety DisordersChronic Pain

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Duloxetine Hydrochloride?

37 organisations hold an active US FDA Type II Drug Master File or a CEP for Duloxetine Hydrochloride: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Lupin Limited (India), MSN Laboratories Private Limited (India), SHANKUS PHARMA PRIVATE LTD (India), Alkem Laboratories Limited (India), Hetero Drugs Limited (India) and Ipca Laboratories Limited (India), and 29 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Duloxetine Hydrochloride Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 23702, 30390), APITORIA PHARMA PRIVATE LTD (DMF 21767, 33633), Lupin Limited (DMF 28961, 21524), MSN Laboratories Private Limited (DMF 35805, 20996), SHANKUS PHARMA PRIVATE LTD (DMF 43451, 43220), Alkem Laboratories Limited (DMF 24685), Hetero Drugs Limited (DMF 25280) and Ipca Laboratories Limited (DMF 40282) and 21 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Duloxetine Hydrochloride records mean?

11 organisations have only inactive Type II DMFs for Duloxetine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Duloxetine Hydrochloride have a European Certificate of Suitability?

Yes. 27 organisations hold a valid CEP for Duloxetine Hydrochloride on the EDQM register, including ZYDUS LIFESCIENCES LIMITED Vadodara (IN), SHANKUS PHARMA PRIVATE LIMITED Mehsana (IN), SHODHANA LABORATORIES PRIVATE LIMITED Medchal Malkajgiri (IN), ALKEM LABORATORIES LIMITED Mumbai (IN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN) and MOEHS IBERICA S.L. Rubi (ES) and 21 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Duloxetine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Duloxetine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.